dual agonist glp 1 Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are The current significance and prospects

Lower levels of IGF-1 and growth hormone in older adults have been linked with (5, 14): increased fat mass increased cardiovascular risk decreased muscle mass and strength lower cognitive function lower bone density limited joint mobility Several of these traits are seen in frail older adults

Its sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu has been shown to modulate delta-wave EEG activity and to interact with NMDA-receptor pathways, though its endogenous precursor remains uncharacterized

Improving alignment can relieve neck tension and prevent further compression of the median nerve

Understanding the Impact of BPC 157 and Gut Health BPC 157, short for Body Protection Compound-157, is a synthetic peptide derived from a protein found in human gastric juice

Pine bark phenolic extracts, current uses, and potential food applications: A review